Vantage Hemp Co. today positioned itself as a global leader in the production of CBD extracts,  with the announcement its facilities have achieved ICH Q7 and WHO Good Manufacturing Practices (GMP) certifications. The certifications recognize Vantage Hemp’s commitment to rigorous pharmaceutical compliance, empowering the company to export its exceptional cannabinoid products worldwide.

[vc_row pix_particles_check=""][vc_column][vc_column_text]To explain what exactly it means to have Good Manufacturing Practices (GMP) is to ensure the consistent quality and safety of products by focusing on five key elements, which are often referred to as the 5 P’s of GMP—people, premises, processes, products and procedures. GMP describes the minimum standard that a pharmaceutical manufacturer must meet in their pharmaceutical-production processes. The European Medicines Agency (EMA) coordinates inspections to verify compliance with these standards and plays a key role in harmonizing GMP activities at European Union (EU) level.